-
Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations.
Cook RR, Foot C, Arah OA, Humphreys K, Rudolph KE, Luo SX, Levander XA, Korthuis PT. Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations. Addiction Science & Clinical Practice 2023;18:11.
-
Design of a pragmatic clinical trial to improve screening and treatment for opioid use disorder in primary care.
Rossom RC, Crain AL, O'Connor PJ, Wright E, Haller IV, Hooker SA, Sperl-Hillen JM, Olson A, Romagnoli K, Solberg L, Dehmer SP, Haapala J, Borgert-Spaniol C, Tusing L, Muegge J, Allen C, Ekstrom H, Huntley K, McCormack J, Bart G. Design of a pragmatic clinical trial to improve screening and treatment for opioid use disorder in primary care. Contemporary Clinical Trials 2023;124:107012.
-
Repurposing ketamine to treat cocaine use disorder: Integration of artificial intelligence-based prediction, expert evaluation, clinical corroboration, and mechanism of action analyses.
Gao Z, Winhusen TJ, Gorenflo M, Ghitza UE, Davis PB, Kaelber DC, Xu R. Repurposing ketamine to treat cocaine use disorder: Integration of artificial intelligence-based prediction, expert evaluation, clinical corroboration, and mechanism of action analyses. Addiction 2023;118(7):1307-1319.
-
Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial.
Vest N, Wenzel K, Choo T, Pavlicova M, Rotrosen J, Nunes EV, Lee JD, Fishman MJ. Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial. American Journal on Addiction 2023;32(3):291-300.
-
Strategies of managing repeated measures: Using synthetic random forest to predict HIV viral suppression status among hospitalized persons with HIV.
Liu J, Pan Y, Nelson MC, Gooden LK, Metsch LR, Rodriguez AE, Tross S, del Rio C, Mandler RN, Feaster DJ. Strategies of managing repeated measures: Using synthetic random forest to predict HIV viral suppression status among hospitalized persons with HIV. AIDS and Behavior 2023;27:2915-2931.
-
Homelessness and treatment outcomes among black adults with opioid use disorder: A secondary analysis of X:BOT.
Justen M, Scodes J, Pavlicova M, Choo T, Gopaldas M, Haeny A, Opara O, Rhee TG, Rotrosen J, Nunes EV, Hawk K, Edelman EJ. Homelessness and treatment outcomes among black adults with opioid use disorder: A secondary analysis of X:BOT. Journal of Addiction Medicine 2023;17(4):463-467.
-
Cannabis and nicotine co-use among primary care patients in a state with legal cannabis access.
McClure EA, Hamilton L, Schauer GL, Matson TE, Lapham GT. Cannabis and nicotine co-use among primary care patients in a state with legal cannabis access. Addictive Behaviors 2023;140:107621.
-
Differential effects of patient navigation across latent profiles of barriers to care among people living with HIV and comorbid conditions.
Traynor SM, Schmidt RD, Gooden LK, Matheson T, Haynes LF, Rodriguez A, Mugavero M, Jacobs P, Mandler RN, del Rio C, Carrico AW, Horigian VE, Metsch LR, Feaster DJ. Differential effects of patient navigation across latent profiles of barriers to care among people living with HIV and comorbid conditions. Journal of Clinical Medicine 2023;12:114.
-
Centering culture in the treatment of opioid use disorder with American Indian and Alaska Native communities: Contributions from a national collaborative board.
Hirchak KA, Nadeau M, Vasquez A, Hernandez-Vallant A, Smith K, Pham C, Oliver KA, Baukol P, Lizzy K, Shaffer R, Herron J, Campbell ANC, Venner KL, CTN-0096 Collaborative Board. Centering culture in the treatment of opioid use disorder with American Indian and Alaska Native communities: Contributions from a national collaborative board. American Journal of Community Psychology 2023;71(1-2):174-183.
-
National Institute on Drug Abuse: Dissemination of scientific knowledge to improve adolescent health.
Subramaniam GA, Nolan L, Huntley K, Corbin M, Crenshaw K, Mandell T, Linton J, Blackeney Q. National Institute on Drug Abuse: Dissemination of scientific knowledge to improve adolescent health. Child and Adolescent Psychiatric Clinics of North America 2023;32(1):157-167.